Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging

被引:70
作者
Fann, M
Chiu, WK
Wood, WH
Levine, BL
Becker, KG
Weng, NP
机构
[1] NIA, Immunol Lab, NIH, Baltimore, MD 21224 USA
[2] NIA, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA
[3] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1111/j.0105-2896.2005.00262.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Accumulation of CD28(null)CD8(+) T cells is considered as one of the hallmarks of aging in the human immune system. However, the precise changes of CD28(null)CD8(+) T cells, compared to those of the precursor CD28(+)CD8(+) memory T cells, have not been determined. In this study, we present an analysis of the global gene expression profiles of CD28(+) and CD28(null) memory phenotype CD8(+) T cells. These two CD8(+) T subsets exhibited an overall similar gene expression profile with only a few dozen genes that were differentially expressed. A wide range of functions, including co-stimulation, effector activity, signaling, and transcription, were possessed by these differentially expressed genes, reflecting significant functional changes of CD28(null) memory phenotype CD8(+) T cells from their CD28(+) counterparts. In addition, CD28(null) memory CD8(+) T cells expressed several natural killer cell receptors and high levels of granzymes, perforin, and FasL, indicating an increasing capacity for cytotoxicity during memory CD8(+) T-cell aging. Interestingly, in vitro culture of these two subsets with interleukin-15 showed that similar gene expression changes occurred in both subsets. Our analysis provides the gene expression portraits of CD28(null) memory phenotype CD8(+) T cells and alteration from their CD28(+) counterparts and suggests potential mechanisms of T-cell aging.
引用
收藏
页码:190 / 206
页数:17
相关论文
共 131 条
[121]   Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses [J].
Wang, SD ;
Chen, LP .
MICROBES AND INFECTION, 2004, 6 (08) :759-766
[122]   CD28 loss in senescent CD4+ T cells:: reversal by interleukin-12 stimulation [J].
Warrington, KJ ;
Vallejo, AN ;
Weyand, CM ;
Goronzy, JJ .
BLOOD, 2003, 101 (09) :3543-3549
[123]   BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 [J].
Watanabe, N ;
Gavrieli, M ;
Sedy, JR ;
Yang, JF ;
Fallarino, F ;
Loftin, SK ;
Hurchla, MA ;
Zimmerman, N ;
Sim, J ;
Zang, XX ;
Murphy, TL ;
Russell, JH ;
Allison, JP ;
Murphy, KM .
NATURE IMMUNOLOGY, 2003, 4 (07) :670-679
[124]  
Weekes MP, 1999, J IMMUNOL, V162, P7569
[125]   IL-15 is a growth factor and an activator of CD8 memory T cells [J].
Weng, NP ;
Liu, KB ;
Catalfamo, M ;
Li, Y ;
Henkart, PA .
MICROARRAYS, IMMUNE RESPONSES AND VACCINES, 2002, 975 :46-56
[126]   Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcεRIγ and CD3ζ [J].
Westgaard, IH ;
Berg, SF ;
Vaage, JT ;
Wang, LL ;
Yokoyama, WM ;
Dissen, E ;
Fossum, S .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 76 (06) :1200-1206
[127]   IL-13 effector functions [J].
Wynn, TA .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :425-456
[128]   A NOVEL CYTOKINE-INDUCIBLE GENE CIS ENCODES AN SH2-CONTAINING PROTEIN THAT BINDS TO TYROSINE-PHOSPHORYLATED INTERLEUKIN-3 AND ERYTHROPOIETIN RECEPTORS [J].
YOSHIMURA, A ;
OHKUBO, T ;
KIGUCHI, T ;
JENKINS, NA ;
GILBERT, DJ ;
COPELAND, NG ;
HARA, T ;
MIYAJIMA, A .
EMBO JOURNAL, 1995, 14 (12) :2816-2826
[129]   Expression of inhibitory receptors in, natural killer (CD3-CD56+) cells and CD3+CD56+ cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma [J].
Yuen, MF ;
Norris, S .
CLINICAL IMMUNOLOGY, 2001, 101 (03) :264-269
[130]   Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15 [J].
Zhang, XH ;
Sun, SQ ;
Hwang, IK ;
Tough, DF ;
Sprent, J .
IMMUNITY, 1998, 8 (05) :591-599